Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.
종목 코드 TLX
회사Telix Pharmaceuticals Ltd
CEOOrtiz (Raphaeel)
웹사이트https://telixpharma.com/
자주 묻는 질문
Telix Pharmaceuticals Ltd(TLX)의 현재 가격은 얼마인가요?
Telix Pharmaceuticals Ltd(TLX)의 현재 주가는 7.800입니다.
Telix Pharmaceuticals Ltd의 종목 기호(Symbol)는 무엇인가요?
Telix Pharmaceuticals Ltd의 종목 코드는 TLX입니다.
Telix Pharmaceuticals Ltd의 52주 최고가는 얼마인가요?
Telix Pharmaceuticals Ltd의 52주 최고가는 30.360입니다.
Telix Pharmaceuticals Ltd의 52주 최저가는 얼마인가요?
Telix Pharmaceuticals Ltd의 52주 최저가는 7.720입니다.
Telix Pharmaceuticals Ltd의 시가총액은 얼마인가요?
Telix Pharmaceuticals Ltd의 시가총액은 --입니다.
Telix Pharmaceuticals Ltd의 순이익은 얼마인가요?
Telix Pharmaceuticals Ltd의 순이익은 --입니다.
Telix Pharmaceuticals Ltd(TLX)의 현재 투자 등급은 매수, 보유, 매도 중 어떤가요?
애널리스트들에 따르면, Telix Pharmaceuticals Ltd(TLX)는 전반적인 평가에서 -- 등급을 받고 있으며, 목표 주가는 --입니다.